Product Information

ATORVASTATIN 20 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0276 per EA under NDC 00093505910. Its NADAC has been published 216 times since Jul 6, 2022.

FDA first approved this application on Mar 27, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ATORVASTATIN 20 MG TABLET

Atorvastatin Calcium
$0.0276per EA

Strength

20 mg/1

NDC

00093505910

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205300

FDA Approved

3/27/2017

TE Code

AB

On Market Since

5/4/2017

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for ATORVASTATIN 20 MG TABLET has been published 216 times since Jul 6, 2022, and over the history we have for it it has declined 39.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0276 per EA
All-time high$0.0514 (Nov 16, 2022)
All-time low$0.0276 (Aug 19, 2026)
52-week high$0.0336
52-week low$0.0276
Median price$0.0356
Average price$0.0366
Largest weekly change+32.4% (Aug 21, 2024)
Weeks tracked216
Tracking sinceJul 6, 2022

Price History

1W

-1.2%

1M

-3.1%

3M

-4.8%

6M

-6.5%

1Y

-17.8%

3Y

-32.1%

5Y

N/A

All

-39.9%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ATORVASTATIN 20 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 20 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0276 per EA (NDC 00093505910), effective Aug 19, 2026.

How has the price of ATORVASTATIN 20 MG TABLET changed over time?

Over the history we have for it, the NADAC for ATORVASTATIN 20 MG TABLET has declined 39.9%. It has been tracked across 216 weekly CMS publications since Jul 6, 2022.

What are the highest and lowest recorded NADAC prices for ATORVASTATIN 20 MG TABLET?

Since Jul 6, 2022, the NADAC for ATORVASTATIN 20 MG TABLET has ranged from a low of $0.0276 (Aug 19, 2026) to a high of $0.0514 (Nov 16, 2022), with a median of $0.0356 per EA.

Are there cheaper alternatives to ATORVASTATIN 20 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ATORVASTATIN 20 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ATORVASTATIN 20 MG TABLET?

ATORVASTATIN 20 MG TABLET (NDC 00093505910) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.